Australia: response to RACGP Medicinal Cannabis Evaluation

The Queensland Health discussion paper 25 highlights the dearth of clinical evidence for the myriad of indications for which cannabis is marketed in Australia. Professor Dr Stuart Reece adds to the cannabis knowledge base in a 60-page response which cites 385 research references plus 90 of his own research papers.